Patient Safety in the Age of Gene Therapy a Central Focus of Review Article
After several decades of preclinical and clinical research, pitfalls and progress, gene therapies for hemophilia A and B have become a reality with recent FDA approvals. While these therapies, along with others still in development, represent both promise and a...
Member Spotlight: Jackson White
Jackson White, VHF Lyman Fisher Scholarship Recipient, 2016 and 2017 As a hemophiliac, I always felt that I had a special connection with biomedical science. So in college I decided to pursue a degree in biophysical chemistry at James Madison University. Upon...
VHF Board Of Directors 2023-2024: Welcome New Members!
July 1, 2023, is the beginning of VHF’s fiscal year, which includes welcoming new board members and thanking those that are rotating off. VHF is fortunate to have dedicated, knowledgeable, and skilled members leading the organization. VHF would like to offer a special...
Camp Youngblood 2023: It Was Great To Be Back!
“After waiting 3 years, Camp Holiday Trails (CHT) was excited to welcome back our Camp Youngblood families to CHT for the first time since 2019. What an amazing week of laughter, new experiences, pranks and of course making lasting memories. We welcomed at least 16...Newsletter Sign Up
Learn more about the bleeding disorders community!